UPLOAD Filing
MOLECULAR PARTNERS AG
Date: April 21, 2025 · CIK: 0001745114 · Accession: 0000000000-25-004220
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286488
Letter
Re: Molecular Partners AG Registration Statement on Form F-3 Filed April 11, 2025 File No. 333-286488 Dear Patrick Amstutz:
April 21, 2025
Patrick Amstutz Chief Executive Officer and Director Molecular Partners AG Wagistrasse 14 8952 Z rich-Schlieren Switzerland
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Brandon Fenn, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 21, 2025 Patrick Amstutz Chief Executive Officer and Director Molecular Partners AG Wagistrasse 14 8952 Z rich-Schlieren Switzerland Re: Molecular Partners AG Registration Statement on Form F-3 Filed April 11, 2025 File No. 333-286488 Dear Patrick Amstutz: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brandon Fenn, Esq. </TEXT> </DOCUMENT>